Summary
The hypothalamic-pituitary-adrenal (HPA)_axis is the major stress response system. Several components of the HPA axis, such as corticotropin-releasing hormone (CRH) and POMC peptides and their receptors are also present in the skin. In earlier studies, we showed that CRH inhibits cellular proliferation of immortalized human keratinocytes. We now examine further the functional activity of the HPA axis in the skin, by characterizing the actions of CRH on normal foreskin keratinocytes. The CRH receptor was detected as CRH-R1 antigen at 47 kDa in the cultured keratinocytes by Western blotting, and immunohistochemistry demonstrated its presence in the epidermal and follicular keratinocytes. CRH is also biologically active in cultured keratinocytes, where it inhibits proliferation and enhances the interferon-γ-stimulated expression of the hCAM and ICAM-1 adhesion molecules and of the HLA-DR antigen. These effects were concentration-dependent, with maximal activity at CRH 107 M. Thus, in the keratinocyte, the most important cellular component of the epidermis, CRH appears to induce a shift in energy metabolism away from proliferation activity, and toward the enhancement of immunoactivity. There fore, similar to its central actions, cutaneous CRH may also be involved in the stress response, but at a highly localized level.
Similar content being viewed by others
References
Baltrop, J. A. 5-(3-carboxymethoxyphenyl)-2-(4,5-dimethylthiazolyl)-3-(4-sulfopheny) tetrazolium, inner salt (MTS) and related analogs of 3-(4,5-dimethylthiazolyl),-2,5-diphenyltetrazolium bromide (MTT) reducing to purple water-soluble formazan as cell-viability indicators. Bioorg. Med. Chem. Lett. 1:611;1991.
Chrousos, G. P. The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. N. Engl. J. Med. 332:1351–1362; 1995.
Crofford, L. J.; Sano, H.; Karalis, K., et al. Corticotropin-releasing hormone in synovial fluids and tissues of patients with rheumatoid arthritis and osteoarthritis. J. Immunol. 151:1587–1596; 1993.
Crofford, L. J.; Sano, H.; Karalis, K.; Webster, E. A.; Friedman, T. C.; Chrousos, G. P.; Wilder, R. L. Local expression of corticotropin-releasing hormone in inflammatory arthritis. Ann. NY Acad. Sci. 771:459–471; 1995.
Crofford, L. J.; Sano, H.; Karalis, K.; Webster, E. L.; Goldmuntz, E. A.; Chrousos, G. P.; Wilder, R. L. Local secretion of corticotropin-releasing hormone in the joints of Lewis rats with inflammatory arthritis. J. Clin. Investig. 90:2555–12564; 1992.
Ekman, R.; Servenius, B.; Castro, M. G.; Lowry, P. J.; Cederlund, A. S.; Bergman, O.; Siogren, H. O. Biosynthesis of corticotropin-releasing hormone in human T-lymphocytes. J. Neuroimmunol. 44:7–13; 1993.
Fazal, N.; Slominski, A.; Choudhry, M. A.; Wei, E. T.; Sayeed, M. M. Effect of CRF and related peptides on calcium signaling in human and rodent melanoma cells. FEBS Lett. 435:187–190; 1998.
Karalis, K.; Sano, H.; Redwine, J.; Listwak, S.; Wilder, R. L.; Chrousos, G. P. Autocrine or paracrine inflammatory actions of corticotropin-releasing hormone in vivo. Science 254:421–423; 1991.
Kiang, J. G.; Poree, L.; Wei, E. T. Anti-inflammatory activity of corticotropin releasing factor: II. Mechanisms of action. Proc. West. Pharmacol. Soc. 30:63–65; 1987.
McCann, S. M.; Lyson, K.; Karanth, S.; Gimeno, M.; Belova, N.; Kamat, A.; Rettori, V. Mechanism of action of cytokines to induce the pattern of pituitary hormone secretion in infection. Ann. NY Acad. Sci. 771:386–395; 1995.
Pastore, S.; Corinti, S.; La Placa, M.; Didona, B.; Girolomoni, G. Inteferongamma promotes exaggerated cytokine production in keratinocytes cultured from patients with atopic dermatitis. J. Allergy Clin. Immunol. 101:538–544; 1998.
Perrin, M. H.; Vale, W.. Corticotropin releasing factor receptors and their ligand family, Ann. NY Acad. Sci. 885:312–328; 1999.
Roloff, B.; Fechner, K.; Slominski, A. et al. Hair cycle-dependent expression of corticotropin-releasing factor (CRF) and CRF receptors in murine skin. FASEB J. 12:287–297; 1998.
Slominski, A. T.; Botchkarev, V.; Choudhry, M., et al. Cutaneous expression of CRH and CRH-R. Is there a “skin stress response systems?” Ann. NY Acad. Sci. 885:287–311; 1999.
Slominski, A.; Mihm, M. C. Potential mechanism of skin resdponse to stress. Int. J. Dermatol. 35:849–851; 1996.
Slominski, A.; Paus, R.; Wortsman, J. On the potential role of proopiomelanocortin in skin physiology and pathology. Mol. Cell. Endocrinol. 93:C1-C6; 1993.
Slominski, A.; Pruski, D. Metatonin inhibits proliferation and melanogenesis in rodent melanoma cells. Exp. Cell Res. 206:189–194; 1993.
Slominski, A.; Roloff, B.; Zbytek, B.; Wei, E. T.; Fechner, K.; Curry, J.; Wortsman, J. Corticotropin releasing hormone and related peptides can act as bioregulatory factors in human keratinocytes. In Vitro Cell. Dev. Biol. 36A:211–216; 2000a.
Slominski, A.; Wortsman, J. Neuroendocrinology of the skin. Endocrine Rev. 21:457–487; 2000b.
Slominski, A.; Wortsman, J.; Luger, T.; Paus, R.; Solomon, S. Corticotropin releasing hormone and proopiomelanocortin involvement in the cutaneous response to stress. Physiol. Rev. 80:979–1020; 2000c.
Slominski, A.; Wortsman, J.; Szczesniewski, A. Liquid chromatography-mass spectrometry (LC-MS) detection of CRH-POMC peptides in human skin. J. Clin. Endocrinol. Metab. 85:3575–3581; 2000d.
Theoharides, T. C.; Singh, L. K.; Boucher, W.; Pang, X.; Letourneau, R.; Webster, E.; Chrousos, G. Corticotropin-releasing hormone induces skin mast cell degranulation and increased vascular permeability, a possible explanation for its proinflammatory effects. Endocrinology 139:403–413; 1998.
Vale, W.; Spiess, J.; Rivier, C.; Rivier, J. Characterization of 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and β-endorphin. Science 213:1394–1397; 1981.
Webster, E. L.; Torpy, D. J.; Elenkov, I. J.; Chrousos, G. P. Corticotropin-releasing hormone and inflammation. Ann. NY Acad. Sci. 840:21–32; 1998.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Quevedo, ME., Slominski, A., Pinto, W. et al. Pleiotropic effects of corticotropin releasing hormone on normal human skin keratinocytes. In Vitro Cell.Dev.Biol.-Animal 37, 50–54 (2001). https://doi.org/10.1290/1071-2690(2001)037<0050:PEOCRH>2.0.CO;2
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1290/1071-2690(2001)037<0050:PEOCRH>2.0.CO;2